Papers

2

Total Citations

410

H-Index

2

About

Dr. Ana Oaknin is a leading oncologist whose research has fundamentally shaped the management of gynecologic malignancies, particularly ovarian and cervical cancers. Her major contributions lie in establishing evidence-based clinical guidelines and advancing surgical techniques. She is the principal author of the highly influential ESMO Clinical Practice Guidelines for non-epithelial ovarian cancer (365 citations), a seminal work that provides a standardized framework for diagnosis, treatment, and follow-up of these rare tumors. Dr. Oaknin has also critically evaluated the efficacy and safety of minimally invasive approaches in radical hysterectomy (45 citations), helping to refine surgical standards for cervical cancer. Her work bridges the gap between clinical research and real-world practice, directly impacting patient outcomes. Through her leadership in guideline development and surgical innovation, Dr. Oaknin has become a trusted voice in gynecologic oncology, guiding clinicians worldwide in delivering optimal, evidence-based care for women with complex reproductive cancers.

Research Focus

Key Achievements

2
H-Index
2
Papers
410
Total Citations
205
Avg Citations/Paper
🏆 Most Cited Paper
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
365 citations · 2018
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago